The role of xenobiotic-metabolizing enzymes in the placenta: a growing research field. Issue 3 (3rd March 2020)

• Record Type: Journal Article
• Authors: Blanco-Castañeda, Ricardo; Galaviz-Hernández, Carlos; Souto, Paula C. S.; Lima, Victor Vitorino; Giachini, Fernanda R.; Escudero, Carlos; Damiano, Alicia E; Barragán-Zúñiga, L. Jazel; Martínez-Aguilar, Gerardo; Sosa-Macías, Martha
• Is Part Of: Expert review of clinical pharmacology. Volume 13:Issue 3(2020)
• Page Start: 247
• Page End: 263
• Publication Date: 2020-03-03
• Subjects: CYP450 enzyme -- drug -- gene expression -- placenta -- placental metabolism -- pregnancy -- transport protein; Clinical pharmacology -- Periodicals; 615.105
• DOI: 10.1080/17512433.2020.1733412
• Languages: English
• ISSNs: 1751-2433

Abstract

ABSTRACT: Introduction : The placenta is a temporary and unique organ that allows for the physical connection between a mother and fetus; this organ regulates the transport of gases and nutrients mediating the elimination of waste products contained in the fetal circulation. The placenta performs metabolic and excretion functions, on the basis of multiple enzymatic systems responsible for the oxidation, reduction, hydrolysis, and conjugation of xenobiotics. These mechanisms give the placenta a protective role that limits the fetal exposure to harmful compounds. During pregnancy, some diseases require uninterrupted treatment even if it is detrimental to the fetus. Drugs and other xenobiotics alter gene expression in the placenta with repercussions for the fetus and mother's well-being. Areas covered : This review provides a brief description of the human placental structure and function, the main drug and xenobiotic transporters and metabolizing enzymes, placenta-metabolized substrates, and alterations in gene expression that the exposure to xenobiotics may cause. Expert opinion : Research should be focused on the identification and validation of biological markers for the assessment of the harmful effects of some drugs in pregnancy, including the evaluation of polymorphisms and methylation patterns in chorionic villous samples and/or amniotic fluid.